New York City-based NYU Langone Health’s Perlmutter Cancer Center and the University of Glasgow in Scotland developed an artificial intelligence-powered tool that was 99% accurate in distinguishing between two lung cancers.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
